摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(η5-C5Me5)(tetrahydrofuran)Cr(CH2)2SiMe2 | 219146-18-6

中文名称
——
中文别名
——
英文名称
(η5-C5Me5)(tetrahydrofuran)Cr(CH2)2SiMe2
英文别名
2-((dimethyl)sila)-1,3-propanediyl-(η(5)-pentamethylcyclopentadienyl)tetrahydrofuranchromium(III);chromium(3+);dimethanidyl(dimethyl)silane;oxolane;1,2,3,4,5-pentamethylcyclopenta-1,3-diene
(η5-C5Me5)(tetrahydrofuran)Cr(CH2)2SiMe2化学式
CAS
219146-18-6
化学式
C18H33CrOSi
mdl
——
分子量
345.541
InChiKey
LZVFYBSWPJKILD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    None
  • 重原子数:
    None
  • 可旋转键数:
    None
  • 环数:
    None
  • sp3杂化的碳原子比例:
    None
  • 拓扑面积:
    None
  • 氢给体数:
    None
  • 氢受体数:
    None

反应信息

  • 作为反应物:
    描述:
    (η5-C5Me5)(tetrahydrofuran)Cr(CH2)2SiMe2正戊烷 为溶剂, 以53%的产率得到bis(μ-trimethylsilylmethylene)bis(η(5)-pentamethylcyclopentadienyl)dichromium(III)
    参考文献:
    名称:
    Structure and Reactivity of Trimethylsilylmethyl Complexes of Chromium, Including the 13-Electron Alkyl Cp*Cr(CH2SiMe3)2
    摘要:
    Alkylation of Cp*Cr(THF)Cl-2 with 1 or 2 equiv of LiCH2SiMe3 yielded the paramagnetic chromium alkyls [Cp*Cr(mu-Cl)(CH2SiMe3)](2) (1), Cp*Cr(CH2SiMe3)(2) (2), and Cp*Cr(L)(CH2SiMe3)(2) (3a, L = py; 3b, L = THF). Compound 2 isa coordinatively unsaturated, pseudo-five-coordinate Cr-III complex with a 13-electron configuration, and it catalyzes the polymerization of ethylene. The thermal decomposition of 2 in noncoordinating solvents proceeded via an intermediate, namely the bis(mu-alkylidene) complex [Cp*Cr(mu-CHSi(CH3)(3))](2) (4). Compound 4 suffered reductive elimination to yield the dinuclear Cr-II alkyl Cp*Cr-2(2)(mu-CH2Si(CH3)(2)CH2-mu-CHSi(CH3)(3)) (5). In contrast, the decomposition of 2 in THF, i.e., 3b, yielded the metallacycles Cp*Cr(L)(CH2)(2)Si(CH3)(3)) (6a, L = py; 6b, L = THF). Compounds 1, 2, 3b, 4, and 5 have been structurally characterized by X-ray diffraction. The reactions of 2 are rationalized in terms of competing alpha- and gamma-hydrogen elimination processes yielding terminal alkylidene and metallacyclobutane intermediates existing in equilibrium.
    DOI:
    10.1021/om980796z
  • 作为产物:
    描述:
    四氢呋喃[(η5-C5Me5)Cr(CH2SiMe3)2]四氢呋喃 为溶剂, 以40%的产率得到(η5-C5Me5)(tetrahydrofuran)Cr(CH2)2SiMe2
    参考文献:
    名称:
    Structure and Reactivity of Trimethylsilylmethyl Complexes of Chromium, Including the 13-Electron Alkyl Cp*Cr(CH2SiMe3)2
    摘要:
    Alkylation of Cp*Cr(THF)Cl-2 with 1 or 2 equiv of LiCH2SiMe3 yielded the paramagnetic chromium alkyls [Cp*Cr(mu-Cl)(CH2SiMe3)](2) (1), Cp*Cr(CH2SiMe3)(2) (2), and Cp*Cr(L)(CH2SiMe3)(2) (3a, L = py; 3b, L = THF). Compound 2 isa coordinatively unsaturated, pseudo-five-coordinate Cr-III complex with a 13-electron configuration, and it catalyzes the polymerization of ethylene. The thermal decomposition of 2 in noncoordinating solvents proceeded via an intermediate, namely the bis(mu-alkylidene) complex [Cp*Cr(mu-CHSi(CH3)(3))](2) (4). Compound 4 suffered reductive elimination to yield the dinuclear Cr-II alkyl Cp*Cr-2(2)(mu-CH2Si(CH3)(2)CH2-mu-CHSi(CH3)(3)) (5). In contrast, the decomposition of 2 in THF, i.e., 3b, yielded the metallacycles Cp*Cr(L)(CH2)(2)Si(CH3)(3)) (6a, L = py; 6b, L = THF). Compounds 1, 2, 3b, 4, and 5 have been structurally characterized by X-ray diffraction. The reactions of 2 are rationalized in terms of competing alpha- and gamma-hydrogen elimination processes yielding terminal alkylidene and metallacyclobutane intermediates existing in equilibrium.
    DOI:
    10.1021/om980796z
点击查看最新优质反应信息

文献信息

  • Voltammetric Study of an Unusual Dimer/Monomer Redox System Involving a Chromium(III) Complex of a Tridentate CNN Ligand
    作者:Somying Leelasubcharoen、Mark W. Lehmann、Klaus H. Theopold、Dennis H. Evans
    DOI:10.1149/1.1346612
    日期:——
    complex of chromium, the metallacycle, Cp * Cr(L)(CH 2 ) 2 Si(CH 3 ) 2 (L=THF), was treated with 2,2'-bipyridine. Instead of producing the desired trimethylsilylmethylidine complex, a new complex (η 5 -(pentamethylcyclopentadienyl)(2(2,2-dimethyl-2-silapropyl)-1,2-dihydro[2,2']bipyridine-1,3-diyl)chromium(III), 1) with a methylene bridge between silicon and the C 2 carbon of the bidentate 2,2'-bipyridine
    在尝试制备的亚烷基配合物时,属环 Cp * Cr(L)(CH 2 ) 2 Si(CH 3 ) 2 (L=THF) 用 2,2'-联吡啶处理。代替产生所需的三甲基甲硅烷基亚甲基复合物,一种新的复合物 (η 5 -(pentamethylcyclopentadienyl)(2(2,2-dimethyl-2-silapropyl)-1,2-dihydro[2,2']bipyridine-1,3-diyl) )铬(III),1)在和二齿2,2'-联吡啶配体的C 2 碳之间形成亚甲基桥。修饰的联吡啶配体包含一个碳和两个氮供体原子(CNN 配体)。当 1 用 [Cp 2 Fe] + [PF 6 ] - 处理时,发生氧化二聚反应,产生连接在每个 2,2'-联吡啶配体的 C 3 碳原子上的二聚体二聚体 (2)。该二聚体被分离为六氟磷酸盐。在目前的工作中,已经探索了 1 和 2 的电化学行为,并且已经表明,1
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-(+)-5,5'',6,6'',7,7'',8,8''-八氢-3,3''-二叔丁基-1,1''-二-2-萘酚,双钾盐 (S)-盐酸沙丁胺醇 (S)-溴烯醇内酯 (S)-7,7-双[(4S)-(苯基)恶唑-2-基)]-2,2,3,3-四氢-1,1-螺双茚满 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2-N-Fmoc-氨基甲基吡咯烷盐酸盐 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-7,7-双[(4S)-(苯基)恶唑-2-基)]-2,2,3,3-四氢-1,1-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-3-(叔丁基)-4-(2,6-二异丙氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-3,3''-双([[1,1''-联苯]-4-基)-[1,1''-联萘]-2,2''-二醇 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-2,2'',3,3''-四氢-6,6''-二-9-菲基-1,1''-螺双[1H-茚]-7,7''-二醇 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (6,6)-苯基-C61己酸甲酯 (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,5R)-3,3a,8,8a-四氢茚并[1,2-d]-1,2,3-氧杂噻唑-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aS,8aR)-2-(吡啶-2-基)-8,8a-二氢-3aH-茚并[1,2-d]恶唑 (3aS,3''aS,8aR,8''aR)-2,2''-环戊二烯双[3a,8a-二氢-8H-茚并[1,2-d]恶唑] (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (3S,3aR)-2-(3-氯-4-氰基苯基)-3-环戊基-3,3a,4,5-四氢-2H-苯并[g]吲唑-7-羧酸 (3R,3’’R,4S,4’’S,11bS,11’’bS)-(+)-4,4’’-二叔丁基-4,4’’,5,5’’-四氢-3,3’’-联-3H-二萘酚[2,1-c:1’’,2’’-e]膦(S)-BINAPINE (3-三苯基甲氨基甲基)吡啶 (3-[(E)-1-氰基-2-乙氧基-2-hydroxyethenyl]-1-氧代-1H-茚-2-甲酰胺) (2′′-甲基氨基-1,1′′-联苯-2-基)甲烷磺酰基铝(II)二聚体 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,4S)-Fmoc-4-三氟甲基吡咯烷-2-羧酸 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,3R)-3-(叔丁基)-2-(二叔丁基膦基)-4-甲氧基-2,3-二氢苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环